Filing Details
- Accession Number:
- 0001437749-23-013936
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-05-11 16:07:46
- Reporting Period:
- 2023-05-09
- Accepted Time:
- 2023-05-11 16:07:46
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1158895 | Lemaitre Vascular Inc | LMAT | Surgical & Medical Instruments & Apparatus (3841) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1366346 | J Lawrence Jasinski | C/O Lemaitre Vascular, Inc. 63 Second Avenue Burlington MA 01803 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-05-09 | 2,500 | $35.48 | 11,810 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2023-05-09 | 1,148 | $48.60 | 12,958 | No | 4 | M | Direct | |
Common Stock | Disposition | 2023-05-09 | 3,648 | $66.00 | 9,310 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2023-05-09 | 2,500 | $0.00 | 2,500 | $35.48 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2023-05-09 | 1,148 | $0.00 | 1,148 | $48.60 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2019-12-20 | 2024-12-20 | No | 4 | M | Direct |
2,296 | 2021-12-11 | 2026-12-11 | No | 4 | M | Direct |
Footnotes
- Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
- This option is fully vested and exercisable.
- Represents a stock option award that vests on a time-based schedule as follows: 33 1/3% of the award vests on the anniversary of the grant date listed in the table, with the balance besting in equal annual installments over the remaining two years.